Related Experiment Video
Updated: Jul 13, 2026
08:26
Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction
Published on: March 24, 2023
Colorectal cancer screening: clinical applications
Judith M E Walsh1, Jonathan P Terdiman
1Division of General Internal Medicine, Department of Medicine, Women's Health Clinical Research Center, University of California San Francisco, Campus Box 1793, 1635 Divisadero Suite 600, San Francisco, CA 94115, USA. Jwalsh@medicine.ucsf.edu
JAMA
|March 14, 2003
Summary
Colorectal cancer screening significantly lowers mortality in adults 50+. Despite available tests, screening rates are low due to patient and physician barriers. Strategies to improve adherence are discussed.
Area of Science:
- Gastroenterology
- Preventive Medicine
- Public Health
Background:
- Colorectal cancer screening reduces mortality in individuals aged 50 years and older.
- Recommended screening tests include fecal occult blood tests, sigmoidoscopy, double-contrast barium enema, and colonoscopy.
- Despite recommendations, colorectal cancer screening rates remain low.
Purpose of the Study:
- To address questions regarding the quality of evidence for various colorectal cancer screening tests.
- To evaluate modifications for high-risk individuals, test availability, and cost-effectiveness.
- To identify patient and physician barriers to colorectal cancer screening and propose strategies to increase compliance.
Main Methods:
- Review of current professional organization recommendations for colorectal cancer screening.
- Analysis of evidence quality for different screening modalities.
- Identification and discussion of barriers to screening adherence.
- Proposal of strategies to enhance screening compliance.
Main Results:
- Multiple screening tests are available and recommended, but their quality of evidence varies.
- Patient-related factors and physician-related factors present significant barriers to screening.
- Cost-effectiveness and availability are key considerations for widespread adoption.
Conclusions:
- Improving colorectal cancer screening rates requires addressing identified patient and physician barriers.
- Evidence quality, risk stratification, availability, and cost-effectiveness must be considered.
- Implementing targeted strategies is crucial to increase adherence and reduce colorectal cancer mortality.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:25Assessment of the Rectum and Anus
Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
01:30Serum Laboratory Studies, Stool Test, Breath Test
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...